EUVIMEDSkopri EUVIMED
Open access

Trilobatin Ameliorates Myocardial Hypertrophy by Enhancing Mitophagy Through Activation of the Sentrin‐Specific Protease 1/Sirtuin 3 Axis in Spontaneously Hypertensive Rats

Ye-Li Li, Yi-Qi Li, Yun-Mei Luo, Yuan-Gui Liu, Jian-Mei Gao iD, Dan-Li Yang, Qi-Hai Gong iD

Phytotherapy Research · 2026

DOI: 10.1002/ptr.70408 ↗

At a glance

Journal article in Phytotherapy Research, 2026. Written by Ye-Li Li and 6 co-authors. Institution: Key Laboratory of Basic Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine of Ministry of Education, …. Major MEDLINE topics: Cardiomegaly, Sirtuins, Mitophagy, Polyphenols. 32 references. The full text is freely available in PubMed Central. Funded by: 111 Project, Guizhou Provincial Major Scientific and Technological Program, Guizhou Provincial Natural Science Foundation.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Myocardial hypertrophy represents a maladaptive response in numerous cardiovascular disorders, and potentiating mitophagy has emerged as a potential therapy. Trilobatin (TLB) possesses multiple pharmacological properties, including the alleviation of cardiotoxicity. However, it remains uncertain whether TLB exerts anti‐hypertrophic effects or, if so, by what mechanisms. This study was designed to determine whether TLB can attenuate hypertrophy and to elucidate the underlying pathways, focusing on mitophagy. We employed in vivo spontaneously hypertensive rats (SHR) and in vitro angiotensin II‐stimulated cardiomyocytes to evaluate anti‐hypertrophic effects. A comprehensive approach was employed, incorporating echocardiography, histological staining, transmission electron microscopy observations, and immunofluorescence to assess phenotypic changes. RNA sequencing, western blotting, immunofluorescence, and ELISA were utilized to elucidate the underlying mechanisms. Additionally, molecular docking, molecular dynamics simulations, and siRNA transfection techniques were applied to identify the target of TLB. The results showed that TLB markedly alleviated hypertrophy in SHR and inhibited angiotensin II‐induced cardiomyocyte hypertrophy. Mechanistically, TLB enhanced mitophagy and reduced oxidative stress via activation of the sentrin‐specific protease 1/sirtuin 3 (SENP1/SIRT3) axis, with direct binding to SENP1. Crucially, SENP1 knockdown abolished TLB's cardioprotective effects, confirming SENP1 as a pivotal mediator. Our findings indicate that TLB exerts anti‐hypertrophic effects by promoting mitophagy and suppressing oxidative injury through the SENP1/SIRT3 axis, highlighting SENP1 as a promising therapeutic target for myocardial hypertrophy.

Subjects

MeSH terms (MEDLINE)

CardiomegalySirtuinsMitophagyPolyphenolsFlavonoidsCysteine EndopeptidasesAnimalsRatsRats, Inbred SHRMyocytes, CardiacOxidative StressMaleAngiotensin IIMolecular Docking Simulation

Author keywords

SENP1/SIRT3 axismitophagymyocardial hypertrophyoxidative stresstrilobatin

Substances

SirtuinstrilobatinPolyphenolsAngiotensin IIFlavonoidsSIRT3 protein, ratCysteine Endopeptidases

Authors and institutions

  • Key Laboratory of Basic Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi Medical University, Zunyi, Guizhou, China.
  • Key Laboratory of Basic Pharmacology of Guizhou Province and School of Pharmacy, Zunyi Medical University, Zunyi, Guizhou, China.
  • Department of Pharmacology, Zunyi Medical University Zhuhai Campus, Zhuhai, Guangdong, China.

ORCID profiles: Jian-Mei Gao, Qi-Hai Gong

Funding

  • 111 Project
  • Guizhou Provincial Major Scientific and Technological Program
  • Guizhou Provincial Natural Science Foundation
  • Health Commission of Guizhou Province Fund Project
  • Zunyi Medical University Postdoctoral Training Fund Project
  • Higher Education Discipline Innovation Project
  • Natural Science Foundation of Guizhou Province

Cite

APA

Li, Y. L., Li, Y. Q., Luo, Y. M., Liu, Y. G., Gao, J. M., Yang, D. L., & Gong, Q. H. (2026). Trilobatin Ameliorates Myocardial Hypertrophy by Enhancing Mitophagy Through Activation of the Sentrin‐Specific Protease 1/Sirtuin 3 Axis in Spontaneously Hypertensive Rats. Phytotherapy Research. https://doi.org/10.1002/ptr.70408

Vancouver

Li YL, Li YQ, Luo YM, Liu YG, Gao JM, Yang DL, et al. Trilobatin Ameliorates Myocardial Hypertrophy by Enhancing Mitophagy Through Activation of the Sentrin‐Specific Protease 1/Sirtuin 3 Axis in Spontaneously Hypertensive Rats. Phytotherapy Research. 2026. doi:10.1002/ptr.70408

BibTeX
@article{Li2026,
  author = {Li, Ye-Li and Li, Yi-Qi and Luo, Yun-Mei and Liu, Yuan-Gui and Gao, Jian-Mei and Yang, Dan-Li and Gong, Qi-Hai},
  title = {Trilobatin Ameliorates Myocardial Hypertrophy by Enhancing Mitophagy Through Activation of the Sentrin‐Specific Protease 1/Sirtuin 3 Axis in Spontaneously Hypertensive Rats},
  journal = {Phytotherapy Research},
  year = {2026},
  doi = {10.1002/ptr.70408}
}
Start for free →